Confidential disclosure agreements, material transfer agreements and term sheets – all these contracts have to be closed during the planning phase of a research project. Mistakes made at this stage can seriously compromise the project. This one-day course on the 24 October 2019 will teach you everything you need to know to avoid such mistakes and…
This year’s innovation prize from the Metropolregion Mitteldeutschland goes to a team that has brought a novel anti-tuberculosis compound all the way from basic research to clinical studies – largely funded by public grants. The winners are Dr Florian Kloß from the Leibniz Institute for Natural Product Research and Infection Biology –…
Be part of Munich’s vibrant bioentrepreneurial ecosystem and join the BioEntrepreneurship Summit on 15 – 16 October 2019. The event is organized by BioM and brings together key players: students, scientists and entrepreneurs (to be) with experienced managers, industry leaders, life-science investors, business angels and tech transfer specialists.…
Ascenion’s portfolio company Berlin Cures has initiated a Phase IIa clinical study with its lead compound BC 007. The two-armed, randomized, open-label trial will evaluate the candidate’s safety and biological efficacy in patients with chronic heart failure. Phase I data demonstrated excellent tolerability, with no clinically relevant side…
BioVaria Start-up Awards go to ISD Immunotech and Mindpax.me 13 May 2019, Munich, Germany – The 12th BioVaria welcomed over 250 life-science innovators to Munich, including biopharma executives, investors, academic inventors, entrepreneurs and technology transfer experts. There were 67 peer-selected licensing opportunities on offer, originating…
Simultaneously Closes Strategic Growth Investment from Ampersand Capital to Create a Leading Provider of Genomic and Cell and Tissue Analysis Products and Services
2 May 2019, Munich - Canopy BiosciencesTM, LLC, a leading provider of gene editing and gene expression products and services, announced today that it has acquired Zellkraftwerk GmbH, a…
BioVaria brings together Europe’s top scientists and technology transfer professionals with potential licensees and investors from the international biopharmaceutical industry. Top-tier academic institutions and universities from all over Europe will present over 60 attractive partnering and investment opportunities in the life-science field.
…
Ascenion’s portfolio company OMEICOS dosed a first patient in a Phase II clinical trial for its lead program OMT-28. The placebo-controlled, double-blind, randomized PROMISE-AF study will evaluate the efficacy and safety of the candidate in patients with persistent atrial fibrillation (AF). In total, the company expects to enrol up to 120…
Join over 400 experts in medical innovation to discuss global challenges and pioneering technologies in healthcare. During two conference days, you will get access to entrepreneurs, scientists and clinicians, policymakers, investors, and industry leaders.
The agenda features influential speakers from Germany, Europe, Israel, the United States,…
The Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS), a location of the Helmholtz Centre for Infection Research (HZI), teams up with the Global Antibiotic Research and Development Partnership (GARDP) to discover novel antibiotics. Ascenion, the HZI’s technology transfer partner, supported the deal.
The partners will focus on…
Gramibactin is an iron-binding molecule of the siderophore family. It occurs naturally in certain plant-associated bacteria where it helps secure the iron supply of both the microorganisms and their host plants. It captures iron(III) from the environment through N nitroso-hydroxylamine groups that have not been observed in any other natural iron…
ISAR Bioscience is sponsor of BioVaria 2019, Europe’s leading showcasing event for life science technologies. ISAR is committed to translational R&D in the field of applied stem cell and regenerative medicine research. ISAR invites scientists and R&D organizations to submit early-stage or more advanced translational R&D project…
Get ready for Europe’s largest event for knowledge and technology transfer (KTT): ASTP-Proton’s Annual Conference is taking place in Dublin on 21 – 23 May 2019. The meeting attracts hundreds of KTT professionals from across the world as well as major stakeholders from industry, SMEs, finance and government. Two interactive days offer multiple…
This is an exciting opportunity for European healthcare entrepreneurs, start-ups and SMEs: EIT Health invites you to apply for participation in the EIT Health Accelerator, a EU-backed programme providing dedicated support at every stage of the business development process, from ideation to scale-up. Supportive actions break down into three key…
Ascenion GmbH, the technology transfer partner of the Helmholtz Centre for Infection Research (HZI), has supported the negotiations for a licence agreement between the institute and InvivoGen, a global provider of life-science research products. Under the terms of the agreement the company obtains the right to commercialise c-di-AMP as a vaccine…
Technology sneak peek from Ascenion: Seven breakthrough life-science inventions
12 March 2019, Munich, Germany – On 8–9 May 2019, decision makers from biotech, pharma and finance will come together in Munich…
Ascenion GmbH, the technology transfer partner of the Helmholtz Centre for Infection Research (HZI), has supported the negotiations for a collaboration agreement between the institute and Evotec. The partners will combine their platforms and expertise to develop antibiotics against resistant pathogens that pose an increasing threat to public…
